Feedback

Russia expresses readiness to transfer Sputnik V production technologies to Ukraine

Source : 112 Ukraine

Russia also agrees to begin clinical trials of the joint vaccine AstraZeneca and Sputnik in Ukraine
13:32, 3 January 2021

RIA Novosti

Russia has expressed its readiness to transfer technologies for the production of the Sputnik V coronavirus vaccine to Ukraine. Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF), announced this.

Related: Medvedchuk: Officials’ refusal to produce Sputnik V vaccine means they should be held accountable for criminal acts against health and life of Ukrainian citizens

According to him, RDIF is ready to fully transfer all the technologies associated with the production of funds. Dmitriev noted that Russia also agrees to begin clinical trials of the joint vaccine AstraZeneca and Sputnik in Ukraine. He stressed that the issue of vaccines should be outside of politics.

As we reported earlier, Russia's Sputnik V coronavirus vaccine has showed 91.4 efficacy, according to data analysis of the final control point of clinical trials. 

"Calculation was based on the analysis of data of volunteers, who received both the first and second doses of the Sputnik V vaccine or placebo at the third and final control point of 78 confirmed cases in accordance with the Phase III clinical trials protocol,"Russian Direct Investment Fund (RDIF) informed.

Meanwhile, the vaccine demonstrated 100 % efficacy against severe coronavirus cases. There were 20 severe cases of coronavirus infection among confirmed cases in the placebo group and no severe cases in the vaccine group.

Related: CovidUkraine: 4,576 new cases over last 24hrs

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more